DE60327696D1 - Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid - Google Patents

Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid

Info

Publication number
DE60327696D1
DE60327696D1 DE60327696T DE60327696T DE60327696D1 DE 60327696 D1 DE60327696 D1 DE 60327696D1 DE 60327696 T DE60327696 T DE 60327696T DE 60327696 T DE60327696 T DE 60327696T DE 60327696 D1 DE60327696 D1 DE 60327696D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
donepezil hydrochloride
composition containing
containing stabilized
donepezil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60327696T
Other languages
English (en)
Inventor
Miha Vrbinc
Kolar Alesa Puncuh
Franc Vrecer
Jordan Berta Kotar
Veronika Stangelj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KRKA dd
Original Assignee
KRKA Tovarna Zdravil dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd
Application granted granted Critical
Publication of DE60327696D1 publication Critical patent/DE60327696D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DE60327696T 2002-06-19 2003-06-18 Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid Expired - Lifetime DE60327696D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200155A SI21223A (sl) 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
PCT/SI2003/000019 WO2004000317A1 (en) 2002-06-19 2003-06-18 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride

Publications (1)

Publication Number Publication Date
DE60327696D1 true DE60327696D1 (de) 2009-07-02

Family

ID=29778199

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60327696T Expired - Lifetime DE60327696D1 (de) 2002-06-19 2003-06-18 Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid

Country Status (15)

Country Link
EP (1) EP1513528B1 (de)
AT (1) ATE431739T1 (de)
AU (1) AU2003279102A1 (de)
CY (1) CY1109314T1 (de)
DE (1) DE60327696D1 (de)
DK (1) DK1513528T3 (de)
EA (1) EA012904B1 (de)
ES (1) ES2326529T3 (de)
HR (1) HRP20041198B1 (de)
PL (1) PL212584B1 (de)
PT (1) PT1513528E (de)
RS (1) RS51824B (de)
SI (2) SI21223A (de)
UA (1) UA86573C2 (de)
WO (1) WO2004000317A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
IL154370A0 (en) * 2003-02-10 2003-09-17 Chemagis Ltd Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
EP1776089A2 (de) * 2003-12-31 2007-04-25 Actavis Group hf Donepezil-formulierungen
EP1579862A1 (de) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
IL171137A (en) 2004-09-29 2012-01-31 Chemagis Ltd Use of purified malt donfazil for the preparation of pure pharmaceutical amorphous donfazil hydrochloride
EP2039349A1 (de) * 2004-10-19 2009-03-25 KRKA, tovarna zdravil, d.d., Novo mesto Feste pharmazeutische Zusammensetzung mit Donepezilhydrochlorid
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
US20060122226A1 (en) 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
JP2007015934A (ja) * 2005-07-05 2007-01-25 Meiko Shoji Kk 温感クリーム化粧料
DE102005060377A1 (de) 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP1920785A1 (de) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
DE102009041839A1 (de) * 2009-09-18 2011-03-24 Dolorgiet Gmbh & Co. Kg Donepezil-haltige Tabletten
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (de) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Feste pharmazeutische Zusammensetzung mit Donepezil
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EP3865120A1 (de) 2013-07-19 2021-08-18 Boehringer Ingelheim Vetmedica GmbH Konservierte veretherte cyclodextrinderivate mit einer flüssigen, wässrigen pharmazeutischen zusammensetzung
CN110721164B (zh) 2013-12-04 2024-09-17 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
US20180344646A1 (en) * 2015-11-25 2018-12-06 Patheon Development Services Inc. Amorphous dispersion granules and oral dosage forms
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
KR102372630B1 (ko) * 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
SI9720038B (sl) * 1996-06-07 2010-06-30 Eisai Co Ltd Polimorfi donepezil hidroklorida in postopek izdelave
EP1027887B1 (de) * 1999-02-10 2008-08-13 Pfizer Products Inc. Vorrichtung mit matrixgesteuerter Wirkstofffreisetzung
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin

Also Published As

Publication number Publication date
EP1513528A1 (de) 2005-03-16
HRP20041198A2 (en) 2005-04-30
ATE431739T1 (de) 2009-06-15
PT1513528E (pt) 2009-08-18
AU2003279102A1 (en) 2004-01-06
RS110604A (en) 2007-02-05
ES2326529T3 (es) 2009-10-14
SI21223A (sl) 2003-12-31
HRP20041198B1 (hr) 2013-05-31
DK1513528T3 (da) 2009-09-07
EA012904B1 (ru) 2010-02-26
EA200500040A1 (ru) 2005-06-30
RS51824B (en) 2012-02-29
PL372116A1 (en) 2005-07-11
WO2004000317A1 (en) 2003-12-31
CY1109314T1 (el) 2014-07-02
PL212584B1 (pl) 2012-10-31
UA86573C2 (ru) 2009-05-12
SI1513528T1 (sl) 2009-10-31
EP1513528B1 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
CY1109314T1 (el) Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης
NO20055568L (no) Substituerte 1,4-diazepiner og anvendelser derav
DK0788481T3 (da) Fremgangsmåde til fremstilling af levobupivacain og analoger deraf
BR9408351A (pt) Composto composição farmacêutica processos para antagonizar o efeito de substância p e de neuroquinina a no seu sitio receptor processos para tratamento ou prevenção de dor ou nocipecção asma fibrose cistica emese e processo para a preparação de um composto
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
UA84146C2 (ru) Амиды пирролопиридин-2-карбоновой кислоты как ингибиторы гликогенфосфорилазы, способ их получения, фармацевтическая композиция и их применение как терапевтических агентов для лечения заболеваний
PE20020084A1 (es) N-(glicilo sustituido)-2-ciano-pirrolidinas como inhibidores de la dipeptidilpeptidasa-iv
JP2003506406A5 (de)
MY136883A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
CA2432578A1 (en) Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
NZ507119A (en) 1-[(4-Piperidinyl)methyl]-4-piperidine derivatives useful for treating gastrointestinal disorders
PL331536A1 (en) Muscarinic antagonists with an etheric bond
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
KR19990028807A (ko) 디페닐메틸렌 피페리딘 유도체
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
ATE403426T1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
CA2462903A1 (en) Beta-lactamyl vasopressin v1a antagonists
EA200700150A1 (ru) Новая фармацевтическая соль 1-бензил-4-[(5,6-диметокси-1-инданон)-2-ил] метилпиперидина (донепезил)
NO20052491L (no) Nye vitronektinresepotr antagonistderivater, fremgangsmate til deres fremstilling, anvendelse derav som legemidler og farmasoytiske sammensetninger som inneholder de samme
MXPA02012119A (es) Modificacion del cristal de fexofenadina.
NZ543068A (en) Substituted 4-(alkyl-amide)-piperidine derivatives, processes for their preparation, and pharmaceutical compositions containing them
PL375163A1 (en) Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition